Literature DB >> 30023292

BAG3-related myofibrillar myopathy requiring heart transplantation for restrictive cardiomyopathy.

Josef Finsterer1, Sinda Zarrouk-Mahjoub2.   

Abstract

Entities:  

Keywords:  Epilepsy; Genotype; Lactic acidosis; Lymphocytes; MELAS; Mitochondrial; Phenotype; Seizures; mtDNA

Year:  2018        PMID: 30023292      PMCID: PMC6047054          DOI: 10.1016/j.ymgmr.2018.02.002

Source DB:  PubMed          Journal:  Mol Genet Metab Rep        ISSN: 2214-4269


× No keyword cloud information.
We read with interest the article by Schänzer et al. about a 9 yo male with restrictive cardiomyopathy (rCMP), myofibrillar myopathy (MFM), and neuropathy due to the BAG3 mutation c.626C>T [1]. The explanted heart was investigated for mutant cardiac tissue abnormalities. We have the following comments/concerns. rCMP is clinically characterised by enlargement of both atria, diastolic dysfunction with a restrictive filling pattern (EA-ratio > 1, deceleration time < 150 ms), and normal systolic function [2]. Were these diagnostic criteria fulfilled in the index patient and all patients of table-1? Which was the reason why one patient carrying the BAG3 variant in table-1 manifested with hypertrophic cardiomyopathy, whereas 11 patients had rCMP? [1] It should be also discussed why one patient had long-QT syndrome and one patient no cardiac involvement [1]. Did the patient with long-QT syndrome [3] carry a second mutation associated with hereditary long-QT syndrome? Was respiratory failure in 10/14 patients of table-1 due to affection of the brainstem, the primary respiratory muscles, or secondary due to heart failure? Differentiation of the causes of respiratory insufficiency is crucial with regard to treatment and outcome. According to table-1 the patient reported by Kostera-Pruszczyk presented with myopathic features on muscle biopsy but did not have a myopathy according to Table 1. This discrepancy should be explained.
Table 1

Phenotypic spectrum of BAG3 mutations.

PhenotypeMutationNOPReference
rCMPc.626C>T14[Schänzer [1], Konersman [5], Lee [6]]
hCMPc.626C>T, c.772C>T1[Schänzer [1]]
dCMPc.913delC1[Rafiq [7]]
long-QT syndromec.626C>T2[Kostera-Pruszczyk [3], Lee [6]]
Respiratory insufficiencyc.626C>T, c.772C>T11[Schänzer [1], Lee [6], Selcen [8], Kostera-Pruszczyk [3]]
Restrictive lung diseasec.626C>T, c.772C>T1[Lee [6]]
Myopathyc.626C>T>20[Schänzer [1]]
Neuropathy (giant axons)c.626C>T>10[Schänzer [1]]
Intracytoplasmic inclusionsc.626C>T6[Schänzer [1]]
Disintegration, disarray of fibersc.626C>T>10[Schänzer [1]]
Dysphagiac.626C>T1[Semmler [9]]
Hypoacusisc.626C>T1[Semmler [9]]
Rigid spinec.626C>T>15[d'Avila [10], Odgerel [11]]

rCMP: restrictive cardiomyopathy, hCMP: hypertrophic cardiomyopathy, dCMP: dilative cardiomyopathy, NOP: number of patients.

Phenotypic spectrum of BAG3 mutations. rCMP: restrictive cardiomyopathy, hCMP: hypertrophic cardiomyopathy, dCMP: dilative cardiomyopathy, NOP: number of patients. The index patient manifested clinically with myopathy, neuropathy, and rCMP. Did he manifest in other systems as well? Was he prospectively investigated for other phenotypic manifestations as frequently observed in BAG3-related FMF (Table 1). Concerning the neuropathy, it would be interesting to know which types of fibers were affected, motor, sensory, or autonomic fibers alone or in combination. Additionally, nerve biopsy in BAG3-related neuropathy may show giant axons [4,5]. Were giant axons found also in the index patient? Overall, this study requires a more widespread clinical description and a more in depth discussion of any inconsistency. There are no conflicts of interest. No funding was received.

Author contribution

JF: design, literature search, discussion, first draft, SZ-M: literature search, discussion, critical comments.
  11 in total

1.  BAG3 myofibrillar myopathy presenting with cardiomyopathy.

Authors:  Chamindra G Konersman; Brett J Bordini; Gunter Scharer; Michael W Lawlor; Steven Zangwill; James F Southern; Louella Amos; Gabrielle C Geddes; Robert Kliegman; Michael P Collins
Journal:  Neuromuscul Disord       Date:  2015-02-04       Impact factor: 4.296

2.  Restrictive cardiomyopathy as a cardiac manifestation of myofibrillar myopathy.

Authors:  Josef Finsterer; Claudia Stöllberger; Romana Höftberger
Journal:  Heart Lung       Date:  2011-04-09       Impact factor: 2.210

3.  BAG3-related myofibrillar myopathy in a Chinese family.

Authors:  H C Lee; S W Cherk; S K Chan; S Wong; T W Tong; W S Ho; A Y Chan; K C Lee; C M Mak
Journal:  Clin Genet       Date:  2011-04-04       Impact factor: 4.438

4.  Mutation in BAG3 causes severe dominant childhood muscular dystrophy.

Authors:  Duygu Selcen; Francesco Muntoni; Barbara K Burton; Elena Pegoraro; Caroline Sewry; Anna V Bite; Andrew G Engel
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

5.  Dysregulated autophagy in restrictive cardiomyopathy due to Pro209Leu mutation in BAG3.

Authors:  A Schänzer; S Rupp; S Gräf; D Zengeler; C Jux; H Akintürk; L Gulatz; N Mazhari; T Acker; R Van Coster; B K Garvalov; A Hahn
Journal:  Mol Genet Metab       Date:  2018-01-06       Impact factor: 4.797

6.  BAG3 mutations: another cause of giant axonal neuropathy.

Authors:  Fatima Jaffer; Sinéad M Murphy; Mariacristina Scoto; Estelle Healy; Alexander M Rossor; Sebastian Brandner; Rahul Phadke; Duygu Selcen; Heinz Jungbluth; Francesco Muntoni; Mary M Reilly
Journal:  J Peripher Nerv Syst       Date:  2012-06       Impact factor: 3.494

7.  Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation.

Authors:  Zagaa Odgerel; Anna Sarkozy; Hee-Suk Lee; Caoimhe McKenna; Julia Rankin; Volker Straub; Hanns Lochmüller; Francalanci Paola; Adele D'Amico; Enrico Bertini; Kate Bushby; Lev G Goldfarb
Journal:  Neuromuscul Disord       Date:  2010-06-03       Impact factor: 4.296

8.  Unusual multisystemic involvement and a novel BAG3 mutation revealed by NGS screening in a large cohort of myofibrillar myopathies.

Authors:  Anna-Lena Semmler; Sabrina Sacconi; J Elisa Bach; Claus Liebe; Jan Bürmann; Rudolf A Kley; Andreas Ferbert; Roland Anderheiden; Peter Van den Bergh; Jean-Jacques Martin; Peter De Jonghe; Eva Neuen-Jacob; Oliver Müller; Marcus Deschauer; Markus Bergmann; J Michael Schröder; Matthias Vorgerd; Jörg B Schulz; Joachim Weis; Wolfram Kress; Kristl G Claeys
Journal:  Orphanet J Rare Dis       Date:  2014-08-01       Impact factor: 4.123

9.  BAG3-related myopathy, polyneuropathy and cardiomyopathy with long QT syndrome.

Authors:  Anna Kostera-Pruszczyk; Małgorzata Suszek; Rafał Płoski; Maria Franaszczyk; Anna Potulska-Chromik; Piotr Pruszczyk; Elżbieta Sadurska; Justyna Karolczak; Anna M Kamińska; Maria Jolanta Rędowicz
Journal:  J Muscle Res Cell Motil       Date:  2015-11-06       Impact factor: 2.698

10.  Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy.

Authors:  Francesca D'Avila; Mirella Meregalli; Sara Lupoli; Matteo Barcella; Alessandro Orro; Francesca De Santis; Clementina Sitzia; Andrea Farini; Pasqualina D'Ursi; Silvia Erratico; Riccardo Cristofani; Luciano Milanesi; Daniele Braga; Daniele Cusi; Angelo Poletti; Cristina Barlassina; Yvan Torrente
Journal:  J Muscle Res Cell Motil       Date:  2016-07-21       Impact factor: 2.698

View more
  1 in total

1.  Response by Aragam et al to Letter Regarding Article, "Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery".

Authors:  Krishna G Aragam; Mark Chaffin; Patrick T Ellinor; Sekar Kathiresan; Steven A Lubitz
Journal:  Circulation       Date:  2019-07-01       Impact factor: 29.690

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.